clofibrate has been researched along with Insulin Sensitivity in 7 studies
angiokapsul: contains clofibrate & insoitolnicotinate
| Excerpt | Relevance | Reference |
|---|---|---|
| " To determine whether PPARalpha activators also improve insulin sensitivity, we measured the capacity of three PPARalpha-selective agonists, fenofibrate, ciprofibrate, and the new compound GW9578, in two rodent models of high fat diet-induced (C57BL/6 mice) or genetic (obese Zucker rats) IR." | 3.70 | Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. ( Berge, RK; Derudas, B; Fruchart, JC; Gervois, P; Guerre-Millo, M; Herbert, JM; Madsen, L; Poulain, P; Raspé, E; Staels, B; Willson, TM; Winegar, DA, 2000) |
| "Metabolic syndrome is associated with increased cardiovascular risk." | 2.41 | [Fibrate influence on lipids and insulin resistance in patients with metabolic syndrome]. ( Idzior-Waluś, B, 2001) |
| "Insulin resistance is a characteristic feature of type II diabetes as well as obesity." | 2.41 | [Discovery and development of a new insulin sensitizing agent, pioglitazone]. ( Fujita, T; Ikeda, H; Kawamatsu, Y; Meguro, K; Sohda, T, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sohda, T | 1 |
| Kawamatsu, Y | 1 |
| Fujita, T | 1 |
| Meguro, K | 1 |
| Ikeda, H | 1 |
| Skrha, J | 1 |
| Sindelka, G | 1 |
| Haas, T | 1 |
| Hilgertová, J | 1 |
| Justová, V | 1 |
| Guerre-Millo, M | 1 |
| Gervois, P | 1 |
| Raspé, E | 1 |
| Madsen, L | 1 |
| Poulain, P | 1 |
| Derudas, B | 1 |
| Herbert, JM | 1 |
| Winegar, DA | 1 |
| Willson, TM | 1 |
| Fruchart, JC | 1 |
| Berge, RK | 1 |
| Staels, B | 1 |
| Bremer, J | 1 |
| Idzior-Waluś, B | 1 |
| Russell, JC | 1 |
| Koeslag, DG | 1 |
| Amy, RM | 1 |
| Dolphin, PJ | 1 |
| Vogelberg, KH | 1 |
| Gries, FA | 1 |
| Dietel, J | 1 |
3 reviews available for clofibrate and Insulin Sensitivity
| Article | Year |
|---|---|
[Discovery and development of a new insulin sensitizing agent, pioglitazone].
Topics: Animals; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Diabetes Mellitus, Experimental; D | 2002 |
The biochemistry of hypo- and hyperlipidemic fatty acid derivatives: metabolism and metabolic effects.
Topics: Animals; Apolipoprotein C-III; Apolipoproteins C; Carnitine O-Palmitoyltransferase; Chylomicrons; Cl | 2001 |
[Fibrate influence on lipids and insulin resistance in patients with metabolic syndrome].
Topics: Cardiovascular Diseases; Clofibrate; Fenofibrate; Hemostasis; Humans; Hyperinsulinism; Hyperlipidemi | 2001 |
4 other studies available for clofibrate and Insulin Sensitivity
| Article | Year |
|---|---|
[Relation between hypertriacylglycerolemia and the action of insulin in type 2 diabetes mellitus].
Topics: Adult; Aged; Clofibrate; Diabetes Mellitus, Type 2; Female; Fenofibrate; Humans; Hypertriglyceridemi | 1994 |
Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity.
Topics: Adipose Tissue; Animals; Butyrates; Clofibrate; Fenofibrate; Hypolipidemic Agents; Insulin Resistanc | 2000 |
Independence of myocardial disease in the JCR:LA-corpulent rat on plasma cholesterol concentration.
Topics: Animals; Apolipoproteins; Arteriosclerosis; Blood Glucose; Cardiomyopathies; Cholesterol; Clofibrate | 1991 |
[Clinical picture and treatment of insulin resistance in primary hyperlipoproteinaemia (author's transl)].
Topics: Blood Glucose; Blood Protein Disorders; Chromatography, Thin Layer; Clofibrate; Diabetes Complicatio | 1973 |